Proxeed® Phototrop® CARNIDYN® RESVIS XR™ |  Bio Record PlusMegasol Q10®

 

 

Nutritional Supplement


  
Megasol Q10
® References
 

  1. O'Keefe JH Jr, Harris WS.  From Inuit to implementation: omega-3 fatty acids come of age. Mayo Clin Proc 2000;75(6):607-14.
     

  2. Mori TA, Woodman RJ. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 2006;9(2):95-104.
     

  3. De Caterina R, Zampolli A, Del Turco S, Madonna R, Massaro M. Nutritional mechanisms that influence cardiovascular disease. Am J Clin Nutr 2006;83(2):421S-426S. 
     

  4. Harris WS. Omega-3 long-chain PUFA and triglyceride lowering: minimum effective intakes. Eur Heart J 2001;3:D59-D61.
     

  5. Roche HM, Gibney MJ. Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state. Lipids 1999;34(Suppl):S259-65.
     

  6. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia.  N Engl J Med 1985;312(19):1210-6.
     

  7. GISSI Group.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354(9177):447-55.
     

  8. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).  Lancet 1989;2(8666):757-61.
     

  9. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death.  N Engl J Med 2002;346(15): 1113-8.
     

  10. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC, Ruskin JN, Manson JE. Fish consumption and risk of sudden cardiac death. JAMA 1998; 279(1):65-6.
     

  11. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274(17):1363-7.
     

  12. Vasudevan AR, Jones PH. Effective use of combination lipid therapy. Curr Atheroscler Rep 2006;8(1):76-84. 
     

  13. Chapidze G, Kapanadze S, Dolidze N, Bachutashvili Z, Latsabidze N. Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins. Georgian Med News 2005;(118):20-5.
     

  14. Strey CH, Young JM, Molyneux SL, George PM, Florkowski CM, Scott RS, Frampton CM. Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. Atherosclerosis 2005;179(1):201-6.